PENG Block Versus LP Block for THA Postop Pain
CompletedPhase 4NCT05261009
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this randomized, double blinded, prospective study is to compare the postoperative analgesia provided by the PENG block to that provided by the LPB for patients undergoing primary anterior approach THA.
Study details
- Official title
- PENG Block Versus LP Block for Postoperative Analgesia After Anterior Total Hip
- Conditions
- Interventions
- Drug: Peri-capsular Nerve Group (PENG)
- Other: Lumbar Plexus Block (LPB)
- Sponsor
- Wake Forest University Health Sciences
- Start date
- 2022-06-13
- Primary completion
- 2023-07-20
- Sex
- All
- Age range
- from 18 Years to 90 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * elective primary total hip arthroplasty surgery anterior approach * provided informed consent * no contraindications to medications used in providing the analgesic blocks Exclusion Criteria: * contraindications to regional anesthesia, such as an allergy to amide local anesthetics * pre-existing coagulopathy or thrombocytopenia \<100,000 * refusal of analgesic block for pain management * presence of an progressive lower extremity neurological deficit * localized or systemic infection * chronic use of high dose opioid analgesics (defined as daily use greater than 60 mg oxycodone equivalents) * pregnant * refusal of consent
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05261009